Naturally, gene therapy approaches are considered for genetic forms of PD (with clinical trials ongoing for GBA1 or LRRK2), but conventional treatments (e.g. levodopa) and deep brain stimulation are effective and the most widely used treatment also for PD [164]. The gene discussed is LRRK2; the disease is Parkinson disease.